Steven Johnson, MD

Professional Titles

• Professor of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine
• Director, University of Colorado HIV Clinical Program
• Medical Director, Colorado AIDS Education and Training Center

Recognitions

• Member, IDSA COVID-19 Treatment Guidelines Panel, 2020-2024, IDSA (2024)
  IDSA guidelines for the management of COVID-19
• Top Doctors in Infectious Disease, Castle Connolly/5280 (2024)
• Lifetime Achievement Award, University of Colorado Hospital Medical Staff (2024)
• 25 Years of Service, St. Mary's Hospital (2024)
  For the HIV Collaborative Clinic
• 25 Years of Service, Mercy Regional Medical Center (2024)
  For the HIV Collaborative Clinic
• Top Doctors in Infectious Disease, 5280 Magazine (2023)
• Member, DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2018-present, NIH (2018)
  DHHS-sponsored federal guidelines panel on antiretroviral treatment for HIV infection
• 25 Years of Service Award, University of Colorado (2018)

Research Interests

Publications

• https://pubmed.ncbi.nlm.nih.gov/39348691/
• https://pubmed.ncbi.nlm.nih.gov/39471458/
• Vincent D. Khuu, Steven C. Johnson, Catherine M. Jankowski, Allison R. Webel, Kristine M. Erlandson. Exercise-Related Syncopal Episodes. 2023 ACSM Annual Meeting & World Congresses, May 30-June 3, 2023, Denver, Colorado.
• Porragas-Paseiro H, Johnson S, Brubaker L, Sanders B. Pneumocystis jirovecii pneumonia complicating methotrexate treatment in a patient with low-risk post-molar gestational trophoblastic neoplasia: A case report and review of the literature. Gynecologic Oncology Reports December 2023, https://doi.org/10.1016/j.gore.2023.101286.
• Barbera L, Kamis K, Rowan S, Davis A, Davis S, Carlson J, Johnson S, Erlandson K. HIV and COVID-19: Review of Clinical Course and Outcomes. HIV Research & Clinical Practice. HIV Res Clin Pract 2021;22(4):102-118. DOI: 10.1080/25787489.2021.1975608.
• Kamis K, Barbera L, Abdo M, Rowan S, Hussain C, Gardner E, Johnson S, MaWhinney S, Davis A, Carlson J, Kozacka K, Erlandson K. Risk factors for hospitalization in people with HIV and COVID-19. JAIDS November 2021;88(3):e22. DOI: 10.1097/QAI.0000000000002780.
• Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H; NIH COVID-19 Treatment Guidelines Panel, Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT Jr, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington C. Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned from COVID-19. Ann Intern Med. 2021;174:1151-1158.
• Abdo M, Ressler A, MaWhinney S, Jankowski C, Johnson S, Erlandson K. End-of-Life Planning Prior to Death Among People Living With HIV. J Assoc Nurses AIDS Care 2021 Jan-Feb 01;32(1):127-133. doi: 10.1097/JNC.0000000000000162.
• Johnson S. Primary Care Concerns for the Aging Population With HIV. Top Antivir Med Oct-Nov 2021;29(4):412-415.
• Krsak M, Montague B, Trowbridge P, Johnson S, Binswanger I. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings vis Telemedicine Guidance and Broader Utilization of Long-acting Medications The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S486–S493, https://doi.org/10.1093/infdis/jiaa001.
• Scherger S, Mathur S, Bajrovic, V, Johnson S, Benamu E, Ramanan P, Wolfel G, Levi M, Abidi M. Cytomegalovirus Myocarditis in Solid Organ Transplant Recipients: A Case Series and Review of Literature. Transplant Infectious Disease 30 March 2020;doi.org/10.1111/tid.13282.
• Krsak M, Johnson S, Poeschla E. COVID-19 Surveillance May Facilitate Return-to-Work Decisions. Am J Trop Med 2020 June;102(6):1189-1190.
• Mundo W, Morales-Shnaider, Tewahade S, Wagner E, Archuleta S, Bandali, M, Chadalawada S, Johnson S, Franco-Paredes C, Shapiro L, Henao-Martinez A. Lower Mortality Associated with Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients with Pneumocystis jirovecii Pneumonia: A Single US Cohort Study and a Propose Novel Mechanism of Corticosteroid Benefit. Open Forum Infectious Diseases, ofaa354, https://doi.org/10.1093/ofid/ofaa354.
• Krsak M, Jeffers A, Shah J, Johnson S, Montague B. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Healthcare in Colorado. Telemedicine and e-Health 5 Sep 2019; https://doi.org/10.1089/tmj.2019.0130.
• Hawkins K, Montague B, Rowan S, Beum R, McLees M, Johnson S, Gardner E. Boosted Darunavir and Dolutegravir Dual Therapy Among a Cohort of Highly Treatment-Experienced Individuals. Antiviral Therapy 20 Sep 2019. DOI: 10.3851/IMP3330 (Epub ahead of print).
• Ressler A, Abdo M, MaWhinney S, Johnson S, Erlandson K. Examining Mortality to Identify Opportunities for Improved Care Among Adults with HIV in a Single Academic Medical Center. AIDS Research and Human Retroviruses 21 Aug 2019. DOI: 10.1089/AID.2019.0154.
• Chand S, Thapa S, Kon, S, Johnson S, Poeschla E, Franco-Parades C, Rodriguez-Morales A, Mattar S, Henao-Martinez A. Hantavirus Infection with Renal Failure and Proteinuria, Colorado, United States, 2019. Emerg Infect Dis. 2020 Feb. https://doi.org/10.3201/eid2602.191349.
• Budgin A, Abidi M, Bajrovic V, Miller M, Johnson S. Severe acute Q fever pneumonia complicated by presumed persistent localized Q fever endocarditis in a renal transplant recipient: A case report and review of the literature. Transplant Infectious Disease, 5 Dec 2019. DOI.org/10.1111/tid.13230.
• Jimmerson L, Morrow M, MaWhinney S, Castillo-Mancilla J, Huntley R, Blum J, Wyles D, Rowan S, Johnson S, Scherrer S, Brooks K, MacBrayne C, Bushman L, Anderson P, Kiser J. Intracellular 007-TP Concentrations are Associated with Gradients of Adherence to Ledipasvir/Sofosbuvir. International Workshop on Clinical Pharmacology of Antiviral Therapy, May 22-24, 2018, Baltimore, Maryland.
• Hawkins K, Montague B, Rowan S, McLees M, Beum R, Johnson S, Gardner E. Sustained Viral Suppression with Dolutegravir and boosted Darunavir Dual Therapy among Highly Treatment-Experienced Individuals. ID Week 2018, October 3-7, 2018, San Francisco, California.
• Ressler A, Johnson S, Abdo M, MaWhinney S, Erlandson K. Non-AIDS Cancers Contribute to an Increasing Proportion of Deaths in Persons Living with HIV at a Single University-Based Clinic. ID Week 2018, October 3-7, 2018, San Francisco, California. 57. Abdo M, Ressler A, MaWhinney S, Johnson S, Erlandson K. Advance Directives and Medical Power of Attorney Assignment in Individuals with HIV. 9th International Workshop on HIV & Aging 2018, September 13-14, 2018, New York, New York.
• Abdo M, Ressler A, MaWhinney S, Johnson S, Erlandson K. Advance Directives and Medical Power of Attorney Assignment in Individuals with HIV. 9th International Workshop on HIV & Aging 2018, September 13-14, 2018, New York, New York.
• Montague B, Johnson S. Immunizations for HIV-Infected Adults. Published on-line, International Antiviral Society-USA Cases on the web, available at www.iasusa.org.
• Rowan S, Rogers M, Bayer J, Smith L, Gardner E, Johnson S, Langness J. Treatment of HCV in HIV coinfected individuals in real world clinical settings: results from two large HIV care clinics. Clinical Infectious Diseases 2016;doi:10.1093/cid/ciw447.
• Rowan S, Rogers M, Bayer J, Smith L, Gardner E, Johnson S, Langness J. Treatment of HCV in HIV Coinfected Individuals in Real World Clinical Settings: Results from Two Large HIV Care Clinics. 11th International Conference on HIV Treatment and Prevention Adherence, May 9-11, 2016, Fort Lauderdale, Florida.
• Lawrence L, Johnson S. HIV Medication Chart. Colorado AIDS Education and Training Center, 2016.
• Lawrence L, Johnson S. HIV Medication Guide. Colorado AIDS Education and Training Center, 2016.
• Johnson S. Antiretroviral Therapy for HIV Infection: When to Initiate Therapy, Which Regimen to Use, and How to Monitor Patients on Therapy. International Antiviral Society-USA. Topics in Antiviral Medicine 2015/2016.
• Starr, W, Johnson S, Bradley-Springer L. First Visit Basics: Initiating Care for the HIV-infected Patient. Mountain-Plains AIDS Education and Training Center, January 2015.
• Starr W, Johnson S, Bradley-Springer L. PEP Steps: A Quick Guide to Post-Exposure Prophylaxis in the Health Care Setting, March 2014.
• Rowen S, Burman B, Johnson S, Connick E, Reirden, Daniloff E, Gardner E. Engagement-in -Care during the first five years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large U.S. city. AIDS Patient Care and STDs 2014, 28:475-481.
• Henao-Martinez A and Johnson S. Clinical and Ethical Challenges: Diagnostic Tests for Syphilis: New Tests and New Algorithms. Neurol Clin Pract 2014,;4:114-122. [Epub ahead of print].
• Starr W, Johnson S, Bradley-Springer L. PEP Steps: A Quick Guide to Post-Exposure Prophylaxis in the Health Care Setting, March 2014.
• “When to Start and What to Use: Translating HIV Treatment Guidelines into Clinical Practice,” CME-Sponsored Video (Medscape), Chapel Hill, North Carolina, 2013 (Hicks C, Johnson S, Eron J, Wohl D)
• Gardner E, Danilloff E, Thrun M, Reirden D, Davidson A, Johnson S, Wilmoth R, Connick E, Burman W. Initial Linkage and Subsequent Retention in HIV Care for a Newly HIV-Diagnosed Cohort in Denver, Colorado. J IAPAC 2013,12:384-390.
• Henao-Martinez A and Johnson S. Clinical and Ethical Challenges: Diagnostic Tests for Syphilis: New Tests and New Algorithms. Published online before print December 2013, doi: 10.1212/01.CPJ.0000435752.17621.48 Neurol Clin Pract
• Langness J, Johnson S, Rogers M, Everson G, Kiser J. Identification and Management of Potential Drug-Drug Interactions with Boceprevir and Telaprevir. 8th International Workshop on Clinical Pharmacology of Hepatitis Therapy, June 26-27, 2013, Cambridge, Massachusetts.
• Rowan S, Burman W, Johnson S, Daniloff E, Wilmoth R, Thrun M, Reirden D, Gardner E. Proportions of a Newly HIV-Diagnosed Cohort of Individuals Participating in Each Step of the HIV Diagnosis and Treatment Cascade during a Six Year Period, Abstract W-234, 19th Conference on Retroviruses and Opportunistic Infection, March 5-8, 2012, Seattle, Washington.
• Rowan S, Levi M, Youngwerth J, Brauer B, Everson G, Johnson S. The Variable Presentation and Broadening Geographic Distribution of Hepatic Fascioliasis. Clinical Gastroenterology and Hepatology, 2012 (in press).
• Henao-Martinez A, Gonzales-Fontal G, Johnson S. Celulitis por Acinetobacter Junii-Johnsonii adquirida en la comunidad: una presentación de caso. Biomedica: Revista del Instituto Nacional de Salud, 2012 (in press).
• Henderson K, Hindman J, Johnson S, Valuck R, Kiser J. Assessing the Effectiveness of Pharmacy-Based Adherence Interventions on Antiretroviral Adherence in Persons with HIV. AIDS Patient Care and STDS, 2011, 25:221-228.
• Merrick D, Bessesen M, Johnson S, Clagett T, Jackson M, Keith R, Byers t, Feser W, Franklin W, Bunn P, Miller Y. Bronchial Dsyplasia is More Frequent and more atypical in biopsy and sputum material from HIV infected subjects: A preliminary report from an ongoing study. 14th World Conference on Lung Cancer, July 3-7, 2011, Amsterdam, The Netherlands.
• Gray J, Reves R, Johnson S, Belknap R. High Frequency of Discordant QuantiFERON-TB Gold In-Tube Test Results When Repeated in an HIV Population with Low Burden of Tuberculosis. Abstract #18794, American Thoracic Society International Conference, Denver, Colorado, May 13-18, 2011
• Astiz M, Burman W, Rierden D, Johnson S, Gardner E. Epidemiology and subsequent engagement in care for a cohort of known HIV-infected individuals who undergo repeat HIV testing. 6th International Conference on HIV Treatment and Prevention Adherence, May 22-24, 2011, Miami Beach, Florida.
• Koeppe J, Lyda K, Johnson S, Armon PhD. Variables Associated with Decreasing Pain Among Persons Living with HIV: A Longitudinal Follow-up Study. Clin J Pain 2011 June 3. [Epub ahead of print].
• Gray J, Johnson S, Reves R, Belknap R. Identification of False-Positive QuantiFeron-TB Gold In-Tube Assays by Repeat Testing in Patents with Human Immunodeficiency Virus and Low Risk for Tuberculosis. E-publication Clinical Infectious Diseases 2011.
• Koeppe J, Armon C, Lyda K, Nielsen C, Johnson S. Ongoing Pain Despite Aggressive Opioid Pain Management Among Persons with HIV. Clinical Journal of Pain, in press, 2010.
• Haukoos J, Hlpkins E, Byyny R, Silverman M, Johnson S, Forsyth J, Wilson M, Thrun M. Performance of Routine Opt-out Rapid HIV Screening in the Emergent Department Still Identifies Patients Late in their Disease Courses. Presentation at Society of Academic Emergency Medicine Meeting, Phoenix, Arizona, June 3-6, 2010.
• Kwong J, Johnson S, Rogers M, Everson G, Bradley-Springer L. Viral Hepatitis and HIV Guide. Mountain-Plains AIDS Education and Training Center, 2010
• Koeppe J, Armon C, Lyda K, Nielsen C, Johnson S. Ongoing pain despite aggressive opioid pain management among persons with HIV. Clin J Pain 2010;26:190-198.
• Haukoos J, Hopkins E, Conroy A, Silverman M, Byyny R, Eisert S, Thrun M, Wilson M, Hutchinson A, Forsyth J, Johnson S, Heffelfinger J, for the Denver Emergency Department HIV Opt-Out Study Group. Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in Emergency Department Patients. JAMA. 2010;304:284-292.
• Carten M, Castillo-Mancilla J, Johnson S. Characteristics of Foreign-Born HIV- Infected Individuals and Differences by Region of Origin and Gender. XVIII International AIDS Conference, Vienna, Austria, July 18-23, 2010.
• Kwong J, Johnson S, Bradley-Springer L. Acute HIV Infection Pocket Guide. Mountain-Plains AIDS Education and Training Center, 2009
• Kwong J, Johnson S, Bradley-Springer L, Thomas E. First Visit Basics: Initiating Care for the HIV-Infected Patient. Mountain-Plains AIDS Education and Training Center, 2009
• Steven C. Johnson. Balancing Adherence Concerns with the Risks of HIV Disease Progression. Clinical Infectious Diseases 2009;48:827-828.
• Kwong J, Davis A, Bradley-Springer L, Johnson S, Ries K, Sweet D, Tight R. HIV: A Sourcebook for the Primary Care Provider. Mountain-Plains AIDS Education and Training Center, 2009.
• Koeppe J, Johnson S. Human Papillomavirus and Squamous Cell Carcinoma of the Anus among Persons with HIV-Infection. Submitted to IAS-USA Cases on the Web.
• Johnson S. Balancing Adherence Concerns with the Risks of HIV Disease Progression. Clinical Infectious Diseases, 2009;48:827-828
• Haukoos J, Hopkins E, Byyny R, Forsyth J, Marlow-Geter A, Johnson S, and Thrum M. Clinical Effectiveness of Routine Opt-Out HIV Screening in the Emergency Department. Presented at the 2008 National Summit on HIV Diagnosis, Prevention, and Access to Care, Arlington, Virginia, November 20-21, 2008.
• Johnson M, Johnson S. Medication Instruction Chart and Pocket Guide. Colorado AIDS Education and Training Center, 2008.
• John Koeppe, Steven Johnson, et al. Suppressive Antibiotic Therapy for Retained Infected Prosthetic Joints: Case Series and Review of the Literature. Infectious Diseases in Clinical Practice 2008;16: 224-229.
• Johnson SC, Kuritzkes DR. Lopinavir. In AIDS Therapy (Editors: R Dolin, H Masur, M. Saag), 3rd Edition, Churchill Livingstone, New York, 2007.
• Koeppe J, Johnson S, Morroni J, Siracusa-Rick C, Armon, C. Suppressive antibiotic therapy for retained, infected prosthetic joints. Infectious Diseases in Clinical Practice, 2008, in press.
• Johnson M, Johnson S. HIV Medication Chart. Colorado AIDS Education and Training Center, 2008.
• Johnson M, Johnson S. HIV Medication Guide. Colorado AIDS Education and Training Center, 2008.
• Johnson SC, Kuritzkes DR. Lopinavir. In AIDS Therapy (Editors: R Dolin, H Masur, M. Saag), 3rd Edition, Churchill Livingstone, New York, in press, 2007.
• Koeppe J, Ogden L, Johnson S. Continued declines in mortality and hospitalization during the 10-year era of highly active antiretroviral therapy in HIV+ patients receiving care at a university-based clinical program. XVIth International AIDS Conference, Toronto, Ontario, Aug 13-18, 2006. Abstract WePe0218.
• Johnson M, Johnson S. HIV Medication Instruction Chart. Colorado AIDS Education and Training Center, 2006.
• Jed S, Johnson S, et al. HIV and Hepatitis Guide. Mountain-Plains AIDS Education and Training Center, 2006
• Jed S, Johnson S, et al. PEP Steps (Guide to Post Exposure Prophylaxis). Mountain-Plains AIDS Education and Training Center, 2006.
• Jed S, Johnson S, et al. NPEP Steps (Guide to Nonoccupational Post Exposure Prophylaxis. Mountain-Plains AIDS Education and Training Center, 2006
• Johnson SC, Kuritzkes DR. Lopinavir. In AIDS Therapy (Editors: R Dolin, H Masur, M. Saag), 3rd Edition, Churchill Livingstone, New York, in press, 2006.
• Johnson M, Johnson S. Medication Instruction Chart. Colorado AIDS Education and Training Center, 2005
• Campbell TB, Shulman N, Johnson SC, Zolopa AR, Young RK, Bushman L, Fletcher CV, Lanier ER, Merigan T, Kuritzkes DR. Antiviral activity of lamivudine in salvage therapy of multidrug-resistant human immunodeficiency virus type 1 infection. Clinical Infectious Diseases 2005; 41:236-242.
• Johnson SC. Book Review: AIDS and other Manifestations of HIV Infection. Clinical Infectious Diseases 2005;40:1866-1867

Professional Memberships

• American College of Physicians (ACP), Fellow
• Infectious Disease Society of America, Fellow
• HIV Medical Association, Member
• International AIDS Society, Member

Practice Locations

• University of Colorado Hospital

Specialty Information

• Internal Medicine, Board Certification (1987)
• Infectious Disease (1990)
• Infectious Disease Recertification, Board Certification (2000)
• Infectious Disease Recertification, Board Certification (2010)
• Infectious Disease Recertification, Board Certification (2020)

• Brain and Nervous System - Meningitis
• Brain and Nervous System - Brain Abscess
• Immune System - AIDS / HIV Disease
• Immune System - Immunodeficiency
• Infections
• Infections - Influenza
• Infections - Pneumonia
• Infections - Sexually Transmitted Diseases
• Brain and Nervous System
• Immune System
• Infections - Bacterial Infections
• Infections - Viral Infections
• Infections - Fungal Infections